Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics, Inc. (DYN) stock — financials & valuation

Key numbers for Dyne Therapeutics, Inc. (DYN): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 33/100 — a percentile rank of Dyne Therapeutics, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Is Dyne Therapeutics, Inc. overvalued? P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Dyne Therapeutics, Inc.’s own financial statements and shown as context, never as advice.